|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.393
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.227
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.224
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.218
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.200
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.181
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.167
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.160
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.159
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.157
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.154
|
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.143
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.139
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.128
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.126
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.122
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.118
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.117
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.111
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.108
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.107
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.106
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.106
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.104
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.095
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.088
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.087
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.086
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.085
|
|
|
|
positive regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000309 |
1 |
0.082
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.079
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.078
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.077
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.077
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.074
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.073
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.072
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.069
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.069
|
|
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.069
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.067
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.066
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.065
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.064
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.063
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.063
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.063
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.062
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.061
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.061
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.059
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.059
|
|
|
|
positive regulation of fibronectin dependent thymocyte migration
|
GO:2000415 |
1 |
0.058
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.057
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.057
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.057
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.056
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.056
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.056
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.054
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
3 |
0.054
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.053
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.053
|
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.052
|
|
|
|
exosomal secretion
|
GO:1990182 |
1 |
0.051
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.049
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.049
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.048
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.047
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.047
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.046
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.046
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.045
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.045
|
|
|
|
sphingoid metabolic process
|
GO:0046519 |
5 |
0.045
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.045
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.043
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.043
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.042
|
|
|
|
fatty acid derivative transport
|
GO:1901571 |
14 |
0.042
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.041
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.041
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.040
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.040
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.039
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.039
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.039
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.038
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.038
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.038
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.038
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.037
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.037
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.037
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.037
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.036
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.036
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.036
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.036
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.036
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.036
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.036
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.035
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.034
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.034
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.034
|
|
|
|
transforming growth factor beta1 production
|
GO:0032905 |
3 |
0.033
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.033
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.033
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.033
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.033
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.032
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.032
|
|
|
|
negative regulation of interleukin 8 secretion
|
GO:2000483 |
1 |
0.032
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.032
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.032
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.031
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.031
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.031
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.030
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.030
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.030
|
|
|
|
glycolipid catabolic process
|
GO:0019377 |
5 |
0.030
|
|
|
|
interleukin 1 alpha secretion
|
GO:0050703 |
3 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
negative regulation of synaptic vesicle transport
|
GO:1902804 |
3 |
0.030
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.029
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.029
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.029
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.029
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.028
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.028
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.028
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.028
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.028
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.028
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
|
regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000307 |
1 |
0.028
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.027
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.027
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.027
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.027
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.027
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.026
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.026
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.026
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.026
|
|
|
|
tumor necrosis factor ligand superfamily member 11 production
|
GO:0072535 |
1 |
0.026
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.026
|
|
|
|
vacuolar transport
|
GO:0007034 |
11 |
0.026
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.026
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.025
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.025
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.025
|
|
|
|
glycosphingolipid catabolic process
|
GO:0046479 |
5 |
0.025
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.025
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.025
|
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.025
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.025
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.025
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.024
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.024
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.024
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.024
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.024
|
|
|
|
regulation of fibronectin dependent thymocyte migration
|
GO:2000413 |
1 |
0.024
|
|
|
|
protein localization involved in establishment of planar polarity
|
GO:0090251 |
1 |
0.024
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.024
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.024
|
|
|
|
pma inducible membrane protein ectodomain proteolysis
|
GO:0051088 |
1 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.023
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.022
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.022
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.022
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
0.022
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.022
|
|
|
|
regulation of vascular smooth muscle contraction
|
GO:0003056 |
1 |
0.022
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.022
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.022
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.021
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.021
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.021
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.021
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.021
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.021
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.021
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.021
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.020
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.020
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.020
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.020
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.020
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.019
|
|
|
|
positive regulation of cell cycle g1 s phase transition
|
GO:1902808 |
9 |
0.019
|
|
|
|
male courtship behavior
|
GO:0008049 |
2 |
0.019
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.019
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
receptor localization to synapse
|
GO:0097120 |
4 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.019
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.019
|
|
|
|
membrane lipid catabolic process
|
GO:0046466 |
8 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.019
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.018
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
positive regulation of transforming growth factor beta1 production
|
GO:0032914 |
2 |
0.018
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.018
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.018
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.018
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.018
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.018
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.017
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.017
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.017
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.017
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.017
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.017
|
|
|
|
icosanoid transport
|
GO:0071715 |
14 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.017
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.017
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.016
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.016
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.016
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.016
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.015
|
|
|
|
regulation of calcium ion dependent exocytosis
|
GO:0017158 |
16 |
0.015
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.015
|
|
|
|
diol metabolic process
|
GO:0034311 |
5 |
0.015
|
|
|
|
positive regulation of g1 s transition of mitotic cell cycle
|
GO:1900087 |
9 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.015
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.015
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.015
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.014
|
|
|
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.014
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.014
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.014
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.014
|
|
|
|
membrane protein ectodomain proteolysis
|
GO:0006509 |
7 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.014
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.014
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.014
|
|
|
|
negative regulation of calcium ion transmembrane transporter activity
|
GO:1901020 |
1 |
0.014
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.014
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.014
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.014
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.014
|
|
|
|
learning
|
GO:0007612 |
98 |
0.014
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.013
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.013
|
|
|
|
positive regulation of interleukin 1 alpha production
|
GO:0032730 |
4 |
0.013
|
|
|
|
germinal center formation
|
GO:0002467 |
16 |
0.013
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.013
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.013
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.013
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.013
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.013
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.013
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.013
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.013
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.013
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.013
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.013
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.013
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.013
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.013
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.013
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.013
|
|
|
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.013
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.012
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.012
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.012
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.012
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.012
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.012
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.012
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.012
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.012
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.012
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.012
|
|
|
|
melanosome transport
|
GO:0032402 |
11 |
0.012
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.012
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.012
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.012
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.012
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.011
|
|
|
|
negative regulation of interleukin 8 production
|
GO:0032717 |
1 |
0.011
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.011
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.011
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.011
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.011
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.011
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.011
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.011
|
|
|
|
lysosomal transport
|
GO:0007041 |
10 |
0.011
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.011
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.011
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.011
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.011
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
|
negative regulation of synaptic vesicle exocytosis
|
GO:2000301 |
3 |
0.011
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.011
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.011
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.011
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.011
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.011
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.011
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.011
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.011
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.011
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.011
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.011
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.011
|
|
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.011
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.010
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.010
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.010
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.010
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.010
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.010
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.010
|
|
|
|
neutrophil homeostasis
|
GO:0001780 |
7 |
0.010
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.010
|
|
|
|
negative regulation of calcium ion transmembrane transport
|
GO:1903170 |
1 |
0.010
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.010
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.010
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.010
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.010
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.010
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.010
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.010
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.010
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.010
|
|